Sign In
Buy AXIM
$0.0052
-0.0002 (-4.07%)
At Close: Jun 02, 2026
AXIM® Biotechnologies Successfully Completes Point-of-Care Clinical Trials on its Rapid COVID-19 Neutralizing Antibody Test
09:00am, Monday, 08'th Mar 2021
SAN DIEGO, March 08, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targetin
